Composite Microgels Loaded with Doxorubicin-Conjugated Amine-Functionalized Zinc Ferrite Nanoparticles for Stimuli-Responsive Sustained Drug Release.
Doxorubicin
/ chemistry
Humans
Delayed-Action Preparations
/ chemistry
Drug Liberation
MCF-7 Cells
Ferric Compounds
/ chemistry
Hydrogen-Ion Concentration
Microgels
/ chemistry
Drug Carriers
/ chemistry
Alginates
/ chemistry
Amines
/ chemistry
Carboxymethylcellulose Sodium
/ chemistry
Nanoparticles
/ chemistry
Zinc
/ chemistry
Zinc Compounds
/ chemistry
Cell Survival
/ drug effects
carboxymethyl cellulose
doxorubicin
microgels
sodium alginate
zinc ferrite nanoparticles
Journal
International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847
Informations de publication
Date de publication:
2024
2024
Historique:
received:
07
11
2023
accepted:
08
03
2024
medline:
5
6
2024
pubmed:
5
6
2024
entrez:
5
6
2024
Statut:
epublish
Résumé
The purpose of this study is to address the need for efficient drug delivery with high drug encapsulation efficiency and sustained drug release. We aim to create nanoparticle-loaded microgels for potential applications in treatment development. We adopted the process of ionic gelation to generate microgels from sodium alginate and carboxymethyl cellulose. These microgels were loaded with doxorubicin-conjugated amine-functionalized zinc ferrite nanoparticles (AZnFe-NPs). The systems were characterized using various techniques. Toxicity was evaluated in MCF-7 cells. In vitro release studies were conducted at different pH levels at 37 The drug encapsulation efficiency of the created carriers was as high as 70%. The nanoparticle-loaded microgels exhibited pH-responsive behavior and sustained drug release. Drug release from them was mediated via a non-Fickian type of diffusion. Given their high drug encapsulation efficiency, sustained drug release and pH-responsiveness, our nanoparticle-loaded microgels show promise as smart carriers for future treatment applications. Further development and research can significantly benefit the field of drug delivery and treatment development.
Identifiants
pubmed: 38836007
doi: 10.2147/IJN.S448594
pii: 448594
pmc: PMC11149627
doi:
Substances chimiques
Doxorubicin
80168379AG
Delayed-Action Preparations
0
Ferric Compounds
0
Microgels
0
Drug Carriers
0
Alginates
0
ferrite
1317-54-0
Amines
0
Carboxymethylcellulose Sodium
K679OBS311
Zinc
J41CSQ7QDS
Zinc Compounds
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5059-5070Informations de copyright
© 2024 Bellala et al.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.